These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 29478510)

  • 1. Plasma Biomarkers of Brain Injury in Neonatal Hypoxic-Ischemic Encephalopathy.
    Massaro AN; Wu YW; Bammler TK; Comstock B; Mathur A; McKinstry RC; Chang T; Mayock DE; Mulkey SB; Van Meurs K; Juul S
    J Pediatr; 2018 Mar; 194():67-75.e1. PubMed ID: 29478510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of High-Dose Erythropoietin With Circulating Biomarkers and Neurodevelopmental Outcomes Among Neonates With Hypoxic Ischemic Encephalopathy: A Secondary Analysis of the HEAL Randomized Clinical Trial.
    Juul SE; Voldal E; Comstock BA; Massaro AN; Bammler TK; Mayock DE; Heagerty PJ; Wu YW; Numis AL;
    JAMA Netw Open; 2023 Jul; 6(7):e2322131. PubMed ID: 37418263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of brain injury and neonatal cytokine response during therapeutic hypothermia in newborns with hypoxic-ischemic encephalopathy.
    Orrock JE; Panchapakesan K; Vezina G; Chang T; Harris K; Wang Y; Knoblach S; Massaro AN
    Pediatr Res; 2016 May; 79(5):742-7. PubMed ID: 26717001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for severity of neonatal hypoxic-ischemic encephalopathy and outcomes in newborns receiving hypothermia therapy.
    Chalak LF; Sánchez PJ; Adams-Huet B; Laptook AR; Heyne RJ; Rosenfeld CR
    J Pediatr; 2014 Mar; 164(3):468-74.e1. PubMed ID: 24332821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Dose Erythropoietin and Hypothermia for Hypoxic-Ischemic Encephalopathy: A Phase II Trial.
    Wu YW; Mathur AM; Chang T; McKinstry RC; Mulkey SB; Mayock DE; Van Meurs KP; Rogers EE; Gonzalez FF; Comstock BA; Juul SE; Msall ME; Bonifacio SL; Glass HC; Massaro AN; Dong L; Tan KW; Heagerty PJ; Ballard RA
    Pediatrics; 2016 Jun; 137(6):. PubMed ID: 27244862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic changes of cerebral-specific proteins in full-term newborns with hypoxic-ischemic encephalopathy.
    Liu F; Yang S; Du Z; Guo Z
    Cell Biochem Biophys; 2013 Jun; 66(2):389-96. PubMed ID: 23203841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum biomarkers of MRI brain injury in neonatal hypoxic ischemic encephalopathy treated with whole-body hypothermia: a pilot study.
    Massaro AN; Jeromin A; Kadom N; Vezina G; Hayes RL; Wang KK; Streeter J; Johnston MV
    Pediatr Crit Care Med; 2013 Mar; 14(3):310-7. PubMed ID: 23392373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin and Brain Magnetic Resonance Imaging Findings in Hypoxic-Ischemic Encephalopathy: Volume of Acute Brain Injury and 1-Year Neurodevelopmental Outcome.
    Mulkey SB; Ramakrishnaiah RH; McKinstry RC; Chang T; Mathur AM; Mayock DE; Van Meurs KP; Schaefer GB; Luo C; Bai S; Juul SE; Wu YW
    J Pediatr; 2017 Jul; 186():196-199. PubMed ID: 28456387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dried blood spot compared to plasma measurements of blood-based biomarkers of brain injury in neonatal encephalopathy.
    Massaro AN; Wu YW; Bammler TK; MacDonald JW; Mathur A; Chang T; Mayock D; Mulkey SB; van Meurs K; Afsharinejad Z; Juul SE
    Pediatr Res; 2019 Apr; 85(5):655-661. PubMed ID: 30661082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine and chemokine responses to injury and treatment in a nonhuman primate model of hypoxic-ischemic encephalopathy treated with hypothermia and erythropoietin.
    Wood TR; Vu PT; Comstock BA; Law JB; Mayock DE; Heagerty PJ; Burbacher T; Bammler TK; Juul SE
    J Cereb Blood Flow Metab; 2021 Aug; 41(8):2054-2066. PubMed ID: 33554708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of hypothermia therapy on serum GFAP and UCH-L1 levels in neonates with hypoxic-ischemic encephalopathy].
    Jiang SH; Wang JX; Zhang YM; Jiang HF
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Dec; 16(12):1193-6. PubMed ID: 25523563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Erythropoietin in the management of Hypoxic Ischaemic Encephalopathy in resource-constrained settings: protocol for a randomized control trial.
    Ezenwa B; Ezeaka C; Fajolu I; Ogbenna A; Olowoyeye O; Nwaiwu O; Opoola Z; Olorunfemi G
    BMC Neurol; 2020 May; 20(1):171. PubMed ID: 32366288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain Injury Outcomes after Adjuvant Erythropoietin Neuroprotection for Moderate or Severe Neonatal Hypoxic-Ischemic Encephalopathy: A Report from the HEAL Trial.
    Wisnowski JL; Monsell SE; Bluml S; Goodman AM; Li Y; Comstock BA; Heagerty PJ; Juul SE; Wu YW; McKinstry RC; Mathur AM;
    Dev Neurosci; 2024; 46(5):285-296. PubMed ID: 37906983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin in perinatal hypoxic-ischemic encephalopathy: a systematic review and meta-analysis.
    Razak A; Hussain A
    J Perinat Med; 2019 May; 47(4):478-489. PubMed ID: 30789826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal hypoxic ischemic encephalopathy-related biomarkers in serum and cerebrospinal fluid.
    Lv H; Wang Q; Wu S; Yang L; Ren P; Yang Y; Gao J; Li L
    Clin Chim Acta; 2015 Oct; 450():282-97. PubMed ID: 26320853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury.
    Robinson S; Winer JL; Berkner J; Chan LA; Denson JL; Maxwell JR; Yang Y; Sillerud LO; Tasker RC; Meehan WP; Mannix R; Jantzie LL
    J Neurosurg Pediatr; 2016 Jun; 17(6):739-55. PubMed ID: 26894518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Value of Neurodevelopmental Outcome and Serum Tau Protein Level in Neonates with Hypoxic Ischemic Encephalopathy.
    Lv HY; Wu SJ; Gu XL; Wang QL; Ren PS; Ma Y; Peng LY; Jin LH; Li LX
    Clin Lab; 2017 Jul; 63(7):1153-1162. PubMed ID: 28792689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL): A Randomized Controlled Trial - Background, Aims, and Study Protocol.
    Juul SE; Comstock BA; Heagerty PJ; Mayock DE; Goodman AM; Hauge S; Gonzalez F; Wu YW
    Neonatology; 2018; 113(4):331-338. PubMed ID: 29514165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma and Cerebrospinal Fluid Candidate Biomarkers of Neonatal Encephalopathy Severity and Neurodevelopmental Outcomes.
    Dietrick B; Molloy E; Massaro AN; Strickland T; Zhu J; Slevin M; Donoghue V; Sweetman D; Kelly L; O'Dea M; McGowan M; Vezina G; Glass P; Vaidya D; Brooks S; Northington F; Everett AD
    J Pediatr; 2020 Nov; 226():71-79.e5. PubMed ID: 32610169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perinatal Asphyxia and Erythropoietin and VEGF: Serial Serum and Cerebrospinal Fluid Responses.
    Sweetman DU; Onwuneme C; Watson WR; Murphy JF; Molloy EJ
    Neonatology; 2017; 111(3):253-259. PubMed ID: 27902983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.